Veer Bhavnagri
General Counsel, Allogene Therapeutics, Inc.
Companies
- Allogene Therapeutics, Inc.General counsel Apr 22, 2020 to Mar 16, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Allogene Therapeutics, Inc. ALLO556,049 shares2$712.9K at $1.28Mar 14, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 14, 2023Shares withheld for tax 23,628 shares at $5.67 of Allogene Therapeutics, Inc.2
- Feb 13, 2023Sold 3,000 shares at $6.85 of Allogene Therapeutics, Inc.3
- Jan 17, 2023Sold 3,000 shares at $7.04 of Allogene Therapeutics, Inc.4
- Dec 15, 2022Sold 5,602 shares at $7.53 of Allogene Therapeutics, Inc.5
- Mar 23, 2022Granted 175,438 shares of Allogene Therapeutics, Inc.6
- Mar 15, 2022Sold 8,849 shares at $7.68 of Allogene Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 14, 2023
- 4SEC EDGARForm 4 filed Jan 18, 2023
- 5SEC EDGARForm 4 filed Dec 19, 2022
- 6SEC EDGARForm 4 filed Mar 25, 2022
- 7SEC EDGARForm 4 filed Mar 17, 2022